What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)

What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)

Bibliographic Details
Main Author:	Fernando Bril, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396421003777

Similar Items

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
by: Ilaria Barchetta, et al.
Published: (2020-10-01)

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
by: Huang J, et al.
Published: (2021-02-01)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
by: Revathy Carnagarin, et al.
Published: (2021-04-01)

From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
by: Kenneth I. Zheng, et al.
Published: (2020-10-01)

Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD)
by: Dyonne Y. Vos, et al.
Published: (2021-08-01)

Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)—A Review
by: Gracjan Różański, et al.
Published: (2021-07-01)

From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
by: Marta Flisiak-Jackiewicz, et al.
Published: (2021-03-01)

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy
by: Jianan Zhao, et al.
Published: (2021-05-01)

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
by: Gu Z, et al.
Published: (2020-08-01)

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
by: Reem Abou Assi, et al.
Published: (2021-03-01)

OP-1 GUT METATRANSCRIPTOMICS AND METABOLOMICS REVEAL ASSOCIATION OF CYSTEINE AND PURINE METABOLISMS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD)
by: Noelia Mazzini Flavia, et al.
Published: (2021-09-01)

The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
by: Rosa Martín-Mateos, et al.
Published: (2021-04-01)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
by: Felix Grabherr, et al.
Published: (2019-09-01)

Mitochondrial dysfunction in non alcoholic fatty liver disease
by: De Alwis, Nimantha M. W.
Published: (2008)

Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease
by: Machado MV
Published: (2021-08-01)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
by: Seong Hee Kang, et al.
Published: (2021-04-01)

Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
by: Parvanescu T, et al.
Published: (2021-04-01)

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
by: Mavidi Sunil Kumar, et al.
Published: (2016-01-01)

Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease
by: Oliveira C.P.M.S., et al.
Published: (2006-01-01)

Liver regeneration in nonalcoholic fatty liver disease
by: Aldo Lagomarsino
Published: (2012-12-01)

Nonalcoholic Fatty Liver Disease
by: Bayard, Max, et al.
Published: (2006)

Cytokines and fatty liver diseases
by: Lukas Niederreiter, et al.
Published: (2018-03-01)

Inactivity and fatty liver disease
by: Marek Rác, et al.
Published: (2016-12-01)

Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01)

Nonalcoholic fatty liver disease
by: Sandra K. Erickson
Published: (2009-01-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
by: Giovanni Targher
Published: (2020-10-01)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
by: Maria Corina Plaz Torres, et al.
Published: (2020-11-01)

METABOLIC SURGERY IN CORRECTION OF FATTY LIVER DISEASE
by: M. B. Fishman, et al.
Published: (2017-02-01)

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
by: Pipop Jirapinyo
Published: (2008-01-01)

Fatty Liver Disease: Metabolic, Genetic, or Both?
by: Heinz Zoller, et al.
Published: (2020-09-01)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
by: Wang Xin, et al.
Published: (2011-12-01)

The fate of fatty liver disease: of bile and fatty acids
by: Frank Grünhage, et al.
Published: (2013-07-01)

Alcoholic liver disease with nonalcoholic fatty liver disease and obesity
by: CAO Haixia
Published: (2019-03-01)

Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
by: Fatema Abu Bakr Abdel-Moez, et al.
Published: (2019-01-01)

Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
by: Maha Assem, et al.
Published: (2018-01-01)

Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
by: Xu Chen, et al.
Published: (2021-09-01)

Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease
by: Alejandro Valencia-Rodríguez, et al.
Published: (2020-05-01)

Nonalcoholic Fatty Liver Disease An Update
Published: (2019)

Metabolic-associated fatty liver disease and lipoprotein metabolism
by: Joerg Heeren, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_v9btq5hquogjsgjt43vssmve42